ORAL-CONTRACEPTIVES AND LIPIDS AND LIPOPROTEINS .2. RELATIONSHIP TO PLASMA STEROID-LEVELS AND OUTLIER STATUS

被引:7
作者
BURKMAN, RT
ZACUR, HA
KIMBALL, AW
KWITEROVICH, P
BELL, WR
机构
[1] JOHNS HOPKINS MED INST,DEPT GYNAECOL & OBSTET,BALTIMORE,MD 21205
[2] JOHNS HOPKINS MED INST,DEPT BIOSTAT,BALTIMORE,MD 21205
[3] JOHNS HOPKINS MED INST,DEPT PEDIAT,BALTIMORE,MD 21205
[4] JOHNS HOPKINS MED INST,DEPT MED,BALTIMORE,MD 21205
关键词
D O I
10.1016/0010-7824(89)90071-1
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:675 / 689
页数:15
相关论文
共 18 条
[1]  
BURKMAN RT, 1988, OBSTET GYNECOL, V71, P33
[2]  
BURKMAN RT, 1988, FERTIL STERIL, V49, pS39
[3]   ORAL-CONTRACEPTIVES AND LIPIDS AND LIPOPROTEINS .1. VARIATIONS IN MEAN LEVELS BY ORAL-CONTRACEPTIVE TYPE [J].
BURKMAN, RT ;
ZACUR, HA ;
KIMBALL, AW ;
KWITEROVICH, P ;
BELL, WR .
CONTRACEPTION, 1989, 40 (05) :553-561
[4]   RISK-FACTORS FOR ACUTE MYOCARDIAL-INFARCTION IN WOMEN - EVIDENCE FROM THE ROYAL-COLLEGE-OF-GENERAL-PRACTITIONERS ORAL CONTRACEPTION STUDY [J].
CROFT, P ;
HANNAFORD, PC .
BRITISH MEDICAL JOURNAL, 1989, 298 (6667) :165-168
[5]   RELATIVE POTENCY OF PROGESTINS USED IN ORAL-CONTRACEPTIVES [J].
DORFLINGER, LJ .
CONTRACEPTION, 1985, 31 (06) :557-570
[6]   ORAL-CONTRACEPTIVES, LIPIDS AND CARDIOVASCULAR-DISEASE [J].
FOTHERBY, K .
CONTRACEPTION, 1985, 31 (04) :367-394
[7]   HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY [J].
GORDON, T ;
CASTELLI, WP ;
HJORTLAND, MC ;
KANNEL, WB ;
DAWBER, TR .
AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) :707-714
[8]   SERUM CHOLESTEROL, LIPOPROTEINS, AND RISK OF CORONARY HEART DISEASE - FRAMINGHAM STUDY [J].
KANNEL, WB ;
CASTELLI, WP ;
GORDON, T ;
MCNAMARA, PM .
ANNALS OF INTERNAL MEDICINE, 1971, 74 (01) :1-+
[9]  
KNOPP RH, 1986, J REPROD MED, V31, P913
[10]   PROGESTINS AND ORAL CONTRACEPTIVE-INDUCED LIPOPROTEIN CHANGES - A PROSPECTIVE-STUDY [J].
LIPSON, A ;
STOY, DB ;
LAROSA, JC ;
MUESING, RA ;
CLEARY, PA ;
MILLER, VT ;
GILBERT, PR ;
STADEL, B .
CONTRACEPTION, 1986, 34 (02) :121-134